Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
November 2014

Recent Stories of Interest

From Specialty Pharmacy News - One Blues plan recently began a partnership with a physician group that the two hope will improve patient outcomes, reduce costs of care and reimburse physicians appropriately. Blue Cross and Blue Shield of Illinois (BCBSIL) and the Illinois Gastroenterology Group (IGG) formed the state’s first specialty intensive medical home (IMH), which is focused on Crohn’s disease. In 2010 three gastroenterology groups merged to form IGG. It now has seven merged groups, making it the largest single-specialty gastroenterology practice in Illinois, and has 48 board-certified gastroenterologists. Read more

Orphan drugs likely do not figure prominently on health plans’ radars. After… Read more

Horizon Blue Cross and Blue Shield of New Jersey is hoping that… Read more

Walgreen Co. allegedly is looking for an investor to purchase a majority… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

November 20, 2014
Clone of Global Drug Spend Will Rise 30% by 2018

IMS Health report predicts 30% increase in global spending on medicines by 2018, to $1.3 trillion. Specialty drugs will contribute 40% of the growth, and almost 200 new drugs are expected to launch in the next five years.

November 18, 2014
Tufts Study Reveals Cost to Develop a Drug

Tufts Cost Study shows estimated average pre-tax cost to develop and market a drug is $2.56 billion.

November 6, 2014
Olysio Gets Expanded Indication in Hep C

FDA approves expanded Olysio label for use in combination with Sovaldi for genotype 1 hepatitis C infection.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?